CRISPR Therapeutics AG (CRSP) Market Capitalization (2016 - 2026)

CRISPR Therapeutics AG has disclosed Market Capitalization across 11 years of filings, most recently posting $5.3 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 22.64% year-over-year to $5.3 billion; the TTM figure through Jun 2026 stood at $5.3 billion (up 22.64% YoY), while the FY2025 annual figure was $5.0 billion, up 49.01% from the prior year.
• Market Capitalization came in at $5.3 billion for Q2 2026 at CRISPR Therapeutics AG, up from $4.6 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $6.1 billion in Q3 2025 to a low of $2.9 billion in Q1 2025.
• Average Market Capitalization over 5 years is $4.5 billion, with a median of $4.6 billion recorded in 2024.
• Year-over-year, Market Capitalization plunged 61.62% in 2022 and jumped 62.11% in 2024.
• Over 5 years, Market Capitalization stood at $3.2 billion in 2022, then surged by 57.0% to $5.0 billion in 2023, then slumped by 32.65% to $3.4 billion in 2024, then soared by 49.01% to $5.0 billion in 2025, then climbed by 4.84% to $5.3 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $5.3 billion in Q2 2026, $4.6 billion in Q1 2026, and $5.0 billion in Q4 2025.